MyFinsight
Home
Blog
About
Contact
vktx: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$2,242K
(29.37%↑ Y/Y)
Prepaid clinical trial
and preclinical...
$21,891K
(389.08%↑ Y/Y)
Short-term investments
available for sale
$614,194K
(-30.21%↓ Y/Y)
Cash and cash
equivalents
$100,376K
(99.37%↑ Y/Y)
Deposits
$46K
(0.00%↑ Y/Y)
Right-of-use assets
$666K
(-40.16%↓ Y/Y)
Total current assets
$738,703K
(-21.13%↓ Y/Y)
Total assets
$739,415K
(-21.16%↓ Y/Y)
Total liabilities and
stockholders equity
$739,415K
(-21.16%↓ Y/Y)
Total stockholders
equity
$713,030K
(-21.77%↓ Y/Y)
Total liabilities
$26,385K
(-0.21%↓ Y/Y)
Accumulated deficit
-$689,884K
(-52.46%↓ Y/Y)
Accumulated other
comprehensive loss
$374K
(-77.08%↓ Y/Y)
Additional paid-in capital
$1,402,539K
(2.95%↑ Y/Y)
Total long-term
liabilities
$318K
(-57.88%↓ Y/Y)
Total current
liabilities
$26,067K
(1.49%↑ Y/Y)
Common stock, 0.00001
par value...
$1K
(0.00%↑ Y/Y)
Lease liability, net
of current portion
$318K
(-57.88%↓ Y/Y)
Lease liability,
current
$437K
(-8.96%↓ Y/Y)
Other accrued
liabilities
$21,217K
(-14.97%↓ Y/Y)
Accounts payable
$4,413K
(1637.40%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)